Cabozantinib-induced serum creatine kinase elevation and rhabdomyolysis: a retrospective case series.

CK elevation may frequently happen during cabozantinib treatment, and in most cases, it may be asymptomatic and may not be clinically problematic. However, medical providers should be aware that symptomatic CK elevations suggestive of rhabdomyolysis may occasionally occur.